Cohort Study to Explore the Therapeutic Effect of Lenvatinib on Differentiated Thyroid Cancer
Not Applicable
- Conditions
- Differentiated Thyroid Cancer
- Registration Number
- JPRN-UMIN000022243
- Lead Sponsor
- Public Health Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 265
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient deemed unsuitable to participate in this study by the attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival
- Secondary Outcome Measures
Name Time Method 1)Time to Treatment Failure 2)Time to Failure of Strategy 3)Progression-Free Survival with clinical Progressive Disease 4)Response Rate 5)QOL survey 6)Safety 7)Patient Reports